Biofrontera AG (BFRA)
Price:
2.67 USD
( - -0.08 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Regeneron Pharmaceuticals, Inc.
VALUE SCORE:
6
2nd position
ADMA Biologics, Inc.
VALUE SCORE:
11
The best
Genmab A/S
VALUE SCORE:
11
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
No data to display
No data to display
No data to display
No data to display
No data to display
No data to display
No data to display
No data to display
DESCRIPTION
Biofrontera AG, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for the treatment of dermatological conditions and diseases caused primarily by exposure to sunlight that results in sun damage to the skin. Its principal product is Ameluz, a prescription drug for the treatment of lesion-directed and field-directed actinic keratosis. The company also offers BF-RhodoLED lamp, a photodynamic therapy for lesion-directed and field-directed treatment of actinic keratosis; and Belixos, an over-the-counter line of skin care cosmetic products. In addition, it is developing Ameluz for the treatment of field cancerization and nodular basal cell carcinoma. Further, the company's product portfolio includes Xepi, a prescription antibiotic cream for the treatment of impetigo; and Aktipak, a generic drug for the treatment of acne. It offers its products primarily in the United States, Europe, and Israel. The company has a collaboration and partnership agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany.
NEWS
Why Is Biofrontera (BFRI) Stock Down Today?
investorplace.com
2024-02-02 08:07:41Biofrontera (NASDAQ: BFRI ) stock is on the move Friday alongside heavy trading of the biopharmaceutical company's shares. This has more than 4.3 million shares of BFRI stock changing hands as of this writing.
BFRI Stock Earnings: Biofrontera Misses EPS, Revenue Estimates
investorplace.com
2023-05-12 08:12:56Biofrontera (NASDAQ: BFRI ) reported results for the first quarter of 2023. Biofrontera posted a loss per share of 28 cents.
Biofrontera AG (BFAGY) Management on Q1 2022 Results - Earnings Call Transcript
seekingalpha.com
2022-05-19 09:10:19Biofrontera AG (OTC:BFAGY) Q1 2022 Earnings Conference Call May 19, 2022 8:00 AM ET Company Participants Anke zur Mühlen - Corporate Communications & Investor Relations Ludwig Lutter - Chief Financial Officer Conference Call Participants Operator Dear ladies and gentlemen, welcome to the conference call of Biofrontera AG. At our customer's request, this conference will be recorded.
Why Biofrontera Stock Is Surging Today
benzinga.com
2022-04-13 15:52:02Biofrontera Inc (NASDAQ: BFRI) shares are trading significantly higher Wednesday after the company announced it received U.S. Food and Drug Administration approval for its cGMP laboratory in Germany. The FDA has approved Biofrontera's German laboratory as a contract lab for batch.
Biofrontera Inc. (BFRI) CEO Erica Monaco on Q4 2021 Results - Earnings Call Transcript
seekingalpha.com
2022-04-08 14:35:04Biofrontera Inc. (BFRI) CEO Erica Monaco on Q4 2021 Results - Earnings Call Transcript
5 Short Squeeze Candidates To Watch: Vinco Ventures, TSR, Biofrontera And More
benzinga.com
2022-02-07 10:42:18Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value instead of falling.
Why Are Biofrontera Shares Rising Today?
benzinga.com
2022-02-01 14:31:10Biofrontera Inc BFRI has provided an update on the patient recruitment for the Phase 3 study for superficial basal cell carcinoma (sBCC) with Ameluz photodynamic therapy (PDT) combined with BF-RhodoLED lamp in the U.S. Thousands of new traders are learning the ins and outs on how to find profitable trades every day with Benzinga Trading School. Click Here Now to Start your FREE Trial.
Is Biofrontera Stock A Buy Or Sell? Several Catalysts In 2022
seekingalpha.com
2021-12-27 09:51:18Biofrontera is eyeing significant growth opportunities for its FDA-approved skin disease photodynamic therapy drug "Ameluz". Updates regarding several ongoing clinical studies for expanded label indications can be a catalyst for the stock in 2022.
What's Going On With Biofrontera Shares Today?
benzinga.com
2021-12-21 16:25:31Biofrontera Inc (NASDAQ:BFRI) is trading higher Tuesday on abnormally-high volume. The stock is seeing increased interest across social media platforms.
Biofrontera Stock (BFRI): Why The Price Surged Today
pulse2.com
2021-12-21 11:25:57The stock price of Biofrontera Inc (NASDAQ: BFRI) increased by over 40% during intraday trading today. This is why it happened.
BFRI Stock Alert: The Social Media Chatter That Has Biofrontera Booming Today
investorplace.com
2021-12-21 11:04:15Biofrontera (BFRI) stock is on the move today as traders take to Twitter (TWTR) to discuss the latest news surrounding the company. The post BFRI Stock Alert: The Social Media Chatter That Has Biofrontera Booming Today appeared first on InvestorPlace.
Biofrontera Shares Are Trading Higher After Benchmark Initiates Coverage
benzinga.com
2021-12-15 13:46:43Benchmark initiated coverage of Biofrontera Inc (NASDAQ:BFRI) with a Buy rating and $11 price target. The Company specializes in medical dermatology, which recently came public in the U.S. as a carve-out from Germany's Biofrontera AG (NASDAQ:BFRA).
Biofrontera Is Promising, But Could Be Limited by Competition and Volatility
investorplace.com
2021-12-13 17:02:12BFRI stock could rise on the company's treatment for actinic keratosis, which can lead to skin cancer, but it has hurdles to overcome first. The post Biofrontera Is Promising, But Could Be Limited by Competition and Volatility appeared first on InvestorPlace.
$20 Price Prediction Is Ambitious but Possible for Biofrontera
investorplace.com
2021-12-07 16:23:19BFRI stock is an imperfect investment as Biofrontera isn't currently profitable, but a new patent could provide a significant revenue source. The post $20 Price Prediction Is Ambitious but Possible for Biofrontera appeared first on InvestorPlace.
Biofrontera (BFRI) Stock: Why The Price Surged Today
pulse2.com
2021-12-02 14:57:48The stock price of Biofrontera Inc (NASDAQ: BFRI) increased by over 27% during intraday trading today. This is why it happened.
Why Are Biofrontera Shares Surging Today?
benzinga.com
2021-12-02 13:36:24The United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Biofrontera Inc (NASDAQ: BFRI) titled "Illumination for Photodynamic Therapy." The patent covers pain-reducing illumination protocol for photodynamic therapy (PDT).
Why Is Biofrontera (BFRI) Stock Down Today?
investorplace.com
2024-02-02 08:07:41Biofrontera (NASDAQ: BFRI ) stock is on the move Friday alongside heavy trading of the biopharmaceutical company's shares. This has more than 4.3 million shares of BFRI stock changing hands as of this writing.
BFRI Stock Earnings: Biofrontera Misses EPS, Revenue Estimates
investorplace.com
2023-05-12 08:12:56Biofrontera (NASDAQ: BFRI ) reported results for the first quarter of 2023. Biofrontera posted a loss per share of 28 cents.
Biofrontera AG (BFAGY) Management on Q1 2022 Results - Earnings Call Transcript
seekingalpha.com
2022-05-19 09:10:19Biofrontera AG (OTC:BFAGY) Q1 2022 Earnings Conference Call May 19, 2022 8:00 AM ET Company Participants Anke zur Mühlen - Corporate Communications & Investor Relations Ludwig Lutter - Chief Financial Officer Conference Call Participants Operator Dear ladies and gentlemen, welcome to the conference call of Biofrontera AG. At our customer's request, this conference will be recorded.
Why Biofrontera Stock Is Surging Today
benzinga.com
2022-04-13 15:52:02Biofrontera Inc (NASDAQ: BFRI) shares are trading significantly higher Wednesday after the company announced it received U.S. Food and Drug Administration approval for its cGMP laboratory in Germany. The FDA has approved Biofrontera's German laboratory as a contract lab for batch.
Biofrontera Inc. (BFRI) CEO Erica Monaco on Q4 2021 Results - Earnings Call Transcript
seekingalpha.com
2022-04-08 14:35:04Biofrontera Inc. (BFRI) CEO Erica Monaco on Q4 2021 Results - Earnings Call Transcript
5 Short Squeeze Candidates To Watch: Vinco Ventures, TSR, Biofrontera And More
benzinga.com
2022-02-07 10:42:18Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value instead of falling.
Why Are Biofrontera Shares Rising Today?
benzinga.com
2022-02-01 14:31:10Biofrontera Inc BFRI has provided an update on the patient recruitment for the Phase 3 study for superficial basal cell carcinoma (sBCC) with Ameluz photodynamic therapy (PDT) combined with BF-RhodoLED lamp in the U.S. Thousands of new traders are learning the ins and outs on how to find profitable trades every day with Benzinga Trading School. Click Here Now to Start your FREE Trial.
Is Biofrontera Stock A Buy Or Sell? Several Catalysts In 2022
seekingalpha.com
2021-12-27 09:51:18Biofrontera is eyeing significant growth opportunities for its FDA-approved skin disease photodynamic therapy drug "Ameluz". Updates regarding several ongoing clinical studies for expanded label indications can be a catalyst for the stock in 2022.
What's Going On With Biofrontera Shares Today?
benzinga.com
2021-12-21 16:25:31Biofrontera Inc (NASDAQ:BFRI) is trading higher Tuesday on abnormally-high volume. The stock is seeing increased interest across social media platforms.
Biofrontera Stock (BFRI): Why The Price Surged Today
pulse2.com
2021-12-21 11:25:57The stock price of Biofrontera Inc (NASDAQ: BFRI) increased by over 40% during intraday trading today. This is why it happened.
BFRI Stock Alert: The Social Media Chatter That Has Biofrontera Booming Today
investorplace.com
2021-12-21 11:04:15Biofrontera (BFRI) stock is on the move today as traders take to Twitter (TWTR) to discuss the latest news surrounding the company. The post BFRI Stock Alert: The Social Media Chatter That Has Biofrontera Booming Today appeared first on InvestorPlace.
Biofrontera Shares Are Trading Higher After Benchmark Initiates Coverage
benzinga.com
2021-12-15 13:46:43Benchmark initiated coverage of Biofrontera Inc (NASDAQ:BFRI) with a Buy rating and $11 price target. The Company specializes in medical dermatology, which recently came public in the U.S. as a carve-out from Germany's Biofrontera AG (NASDAQ:BFRA).
Biofrontera Is Promising, But Could Be Limited by Competition and Volatility
investorplace.com
2021-12-13 17:02:12BFRI stock could rise on the company's treatment for actinic keratosis, which can lead to skin cancer, but it has hurdles to overcome first. The post Biofrontera Is Promising, But Could Be Limited by Competition and Volatility appeared first on InvestorPlace.
$20 Price Prediction Is Ambitious but Possible for Biofrontera
investorplace.com
2021-12-07 16:23:19BFRI stock is an imperfect investment as Biofrontera isn't currently profitable, but a new patent could provide a significant revenue source. The post $20 Price Prediction Is Ambitious but Possible for Biofrontera appeared first on InvestorPlace.
Biofrontera (BFRI) Stock: Why The Price Surged Today
pulse2.com
2021-12-02 14:57:48The stock price of Biofrontera Inc (NASDAQ: BFRI) increased by over 27% during intraday trading today. This is why it happened.
Why Are Biofrontera Shares Surging Today?
benzinga.com
2021-12-02 13:36:24The United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Biofrontera Inc (NASDAQ: BFRI) titled "Illumination for Photodynamic Therapy." The patent covers pain-reducing illumination protocol for photodynamic therapy (PDT).